ISSN: 0975-0851
Statistical considerations in biosimilar assessment using biosimilarity index
In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation
View More »
Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report
Research Article
Bioequivalence Study of Modified Release Formulations of Trimetazidine 35 mg MR Tablets in Healthy Thai Subjects: Single Dose under Fasting Condition, Single Dose Under Fed Condition and Multiple Dose Under Fed Condition.
DOI: 10.35248/0975-0851.24.16.555
Brief Report
Use of Reverse Blood Grouping to Identify Plasma Samples Switched between Subjects in a Pharmacokinetic Study
DOI: 10.35248/0975-0851.24.16.556
Bioequivalence Study of Dapagliflozin 10 mg Film Coated Tablets in Healthy Indonesian Subjects under Fasting Condition
DOI: 10.35248/0975-0851.24.16.557
Perspective
Improving Therapy and the Significance of Therapeutic Drug Surveillance
DOI: 10.35248/0975-0851.24.16.558
The Significance of Drug Bioanalysis and Clinical Pharmacology
DOI: 10.35248/0975-0851.24.16.559
Developing Drug Presentation to Improve Patient Adherence and Innovative Methods
DOI: 10.35248/0975-0851.24.16.560
Commentary Article
The Crucial Role of Bioequivalency Testing in Pharmaceutical Quality Testing
DOI: 10.35248/0975-0851.24.16.561
Pharmacogenetics Based Genomic Strategies for Precision Medicine and Treatment Methods
DOI: 10.35248/0975-0851.24.16.562
Opinion Article
The Significance of Bioequivalency and Bioavailability Management in Improving Patient Health
DOI: 10.35248/0975-0851.24.16.563
Transdermal Pharmacological Equivalency and Advancing Innovation in Medicine
DOI: 10.35248/0975-0851.24.16.564